Also known as: RESEARCHERS
Fellowship Of Orthopeadic Researchers Inc. is a private corporation based in METAIRIE, LA. The foundation received its IRS ruling in 2000. The principal officer is % Stephen D Cook Phd. It holds total assets of $903K. Annual income is reported at $1.2M. BROWN CARTILAGE (CARTILAGE REPAIR & REGENERATION PROGRAM)PATIENTS, WHOSE ACTIVITIES ARE LIMITED DUE TO ARTHRITIC KNEES BUT WHOSE PAIN IS NOT YET SEVERE ENOUGH TO WARRANT A TOTAL KNEE REPLACEMENT, FACE A PAUCITY OF TREATMENT OPTIONS. THE ARTICULAR CARTILAGE REPLACEMENT PROGRAM HAS SUCCESSFULLY DEVELOPED A NOVEL MINIMALLY INVASIVE DEVICE TO REPLACE THE LOST AND DAMAGED CARTILAGE AND BONE IN THE MEDIAL CONDYLE AND THE PATELLA OF THE KNEE IN THESE PATIENTS. THIS TECHNOLOGY HAS BEEN FULLY DEVELOPED INTO A CLINICAL TRIAL READY IMPLANT SYSTEM. DURING 2022, THE FOUNDATION CONTINUED TO EXPLORE PARTNERS AND DONORS TO MAKE THIS TREATMENT AVAILABLE TO PATIENTS. THE INTELLECTUAL PROPERTY DEVELOPED HAS BEEN MAINTAINED AND THE R AND D ACTIVITIES ARE WINDING DOWN. OPPORTUNITIES TO EXPLOIT THE TECHNOLOGY WERE SOUGHT. Contributions to this foundation are tax-deductible.
BROWN CARTILAGE (CARTILAGE REPAIR & REGENERATION PROGRAM)PATIENTS, WHOSE ACTIVITIES ARE LIMITED DUE TO ARTHRITIC KNEES BUT WHOSE PAIN IS NOT YET SEVERE ENOUGH TO WARRANT A TOTAL KNEE REPLACEMENT, FACE A PAUCITY OF TREATMENT OPTIONS. THE ARTICULAR CARTILAGE REPLACEMENT PROGRAM HAS SUCCESSFULLY DEVELOPED A NOVEL MINIMALLY INVASIVE DEVICE TO REPLACE THE LOST AND DAMAGED CARTILAGE AND BONE IN THE MEDICAL CONDYLE AND THE PATELLA OF THE KNEE IN THESE PATIENTS. THIS PROGRAM BEGAN WITH A THOROUGH LITERATURE SEARCH AND ANATOMIC STUDIES OF THE KNEE. AN ANALYSIS OF THE ECONOMIC OPTIMIZATION FOR TREATMENTS FOR THE KNEE WAS ALSO UNDERTAKEN TO ASSESS THE VIABILITY OF VARIOUS NOVEL APPROACHES. NEXT, A SERIES OF PROTOTYPE IMPLANTS AND INSTRUMENTS WERE DEVELOPED TO MEET THE DESIGN CRITERIA OF THE IMPLANTS FOR BOTH THE MEDICAL CONDYLE AND THE PATELLA. ONCE THE DESIGN WAS FINALIZED, PROGRAMS OF EXTENSIVE MECHANICAL TESTING AND IN VIVO ANIMAL STUDY WERE UNDER TAKEN.
Expenses: $16K
BROWN PROSTHESIS (DIRECT TO SKELETON ATTACHMENT PROSTHESIS PROGRAM)RECOVERY FROM AN AMPUTATION IS A LONG AND COMPLEX PROCESS, OFTEN PRODUCING LESS THAN DESIRABLE RESULTS. EVEN A REHABILITATION THAT IS TERMED SUCCESSFUL WILL OFTEN INVOLVE COMPLICATIONS SUCH AS RESIDUAL LIMB SKIN BREAKDOWN, PAIN AND POOR CONTROL OF THE PROSTHETIC LIMB. THE PROSTHETIC ATTACHMENT PROGRAM HAS SOUGHT TO DEVELOP A PROSTHETIC LIMB IN WHICH AN IMPLANT WITHIN THE RESIDUAL LIMB REACTS WITH THE PROSTHETIC SOCKET TO PROVIDE A STABLE, NON-CONTACT CONNECTION BETWEEN THE PATIENT AND THE PROSTHESIS. THE INTERACTION OF THE SPECIALLY DESIGNED MAGNETIC SYSTEM RESULTS IN A SYSTEM OF FORCES, BY WHICH THE PROSTHESIS AND THE PATIENT'S SKELETON ARE HELD IN MECHANICAL EQUILIBRIUM, ELIMINATING PAIN AND SOFT TISSUE COMPLICATIONS ASSOCIATED WITH TRADITIONAL LIMB PROSTHESES.
Expenses: $8K
MARSHAL "MAGNETIC SPINAL IMPLANT" PROGRAMINSTABILITY AND DEGENERATION OF THE SPINE IS A DEBILITATING CONDITION THAT AFFECTS MILLIONS OF PEOPLE. TREATMENTS TYPICALLY INVOLVE SURGICAL STABILIZATION WITH VARYING RESULTS AND WIDE VARIATION IN OUTCOMES. THE PURPOSE OF THE MARSHAL "MAGNETIC SPINAL IMPLANT" PROGRAM IS TO EXPLORE AND DETERMINE THE VIABILITY OF THE USE OF MAGNETS TO STABILIZE AND RECONSTRUCT THE SPINE SAFELY, AND WITH IMPROVEMENT OVER CURRENT TREATMENTS AND TECHNOLOGIES, THERE BY RELIEVING PAIN AND SUFFERING. THE GOAL OF THE PROGRAM IS TO EXPLORE THE FEASIBILITY OF THIS STRATEGY AND DEVELOP A COMMERCIALLY VIABLE DEVICE THAT USES MAGNETIC TECHNOLOGY. IN 2019 THE PROGRAM FURTHER EXPLORED THE REGULATORY PATHWAY, FEASIBILITY OF VARIOUS MAGNETIC TECHNOLOGIES AND BIOCOMPATIBLE COATING TECHNOLOGIES, AND THE ANATOMIC AND OTHER TECHNICAL REQUIREMENT FOR AN IMPLANTABLE DEVICE FOR THE STABILIZATION OF THE CERVICAL SPINE.
BROWN CARTILAGE (CARTILAGE REPAIR & REGENERATION PROGRAM)PATIENTS, WHOSE ACTIVITIES ARE LIMITED DUE TO ARTHRITIC KNEES BUT WHOSE PAIN IS NOT YET SEVERE ENOUGH TO WARRANT A TOTAL KNEE REPLACEMENT, FACE A PAUCITY OF TREATMENT OPTIONS. THE ARTICULAR CARTILAGE REPLACEMENT PROGRAM HAS SUCCESSFULLY DEVELOPED A NOVEL MINIMALLY INVASIVE DEVICE TO REPLACE THE LOST AND DAMAGED CARTILAGE AND BONE IN THE MEDIAL CONDYLE AND THE PATELLA OF THE KNEE IN THESE PATIENTS. THIS TECHNOLOGY HAS BEEN FULLY DEVELOPED INTO A CLINICAL TRIAL READY IMPLANT SYSTEM. DURING 2022, THE FOUNDATION CONTINUED TO EXPLORE PARTNERS AND DONORS TO MAKE THIS TREATMENT AVAILABLE TO PATIENTS. THE INTELLECTUAL PROPERTY DEVELOPED HAS BEEN MAINTAINED AND THE R AND D ACTIVITIES ARE WINDING DOWN. OPPORTUNITIES TO EXPLOIT THE TECHNOLOGY WERE SOUGHT.
Fellowship Of Orthopeadic Researchers Inc. typically selects its grantees rather than accepting unsolicited proposals.
Fellowship Of Orthopeadic Researchers Inc. is headquartered in METAIRIE, LA.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Stephen D Cook Phd | DIRECTOR | $233K | $16K | $249K |
| Samantha L Salkeld | DIRECTOR | $151K | $17K | $168K |
Total Giving
$1.1M
Total Assets
$1M
Fair Market Value
$1M
Net Worth
$972K
Grants Paid
$0
Contributions
$713K
Net Investment Income
$37K
Distribution Amount
$0
Expenses: $176K
MAGNETIC SPINAL APPLICATIONS PROGRAMINSTABILITY AND DEGENERATION OF THE SPINE IS A DEBILITATING CONDITION THAT AFFECTS MILLIONS OF PEOPLE. TREATMENTS TYPICALLY INVOLVE SURGICAL STABILIZATION WITH VARYING RESULTS AND WIDE VARIATION IN OUTCOMES. IN 2020, THE FOUNDATION BEGAN RESEARCH AND DEVELOPMENT ON THE MAGNETIC SPINAL APPLICATIONS PROGRAM TO BUILD ON THE TECHNOLOGIES AND APPLY KNOWLEDGE GAINED IN EARLIER RELATED BASIC SCIENCE PROGRAMS. YEAR 2020 ACTIVITIES INCLUDED ITERATIVE 3-DIMENSIONAL MODELLING OF OPTIMIZED MAGNETIC FIELD CONFIGURATION, SIMULATED IMPLANT DESIGNS, AND THEIR INTERACTIONS WITH MODELS OF THE HUMAN BODY WERE CONDUCTED. OTHER ACTIVITIES AND ACHIEVEMENTS IN 2020 INCLUDED PROTOTYPE DESIGN AND CREATION, AND IDENTIFYING VENDORS QUALIFIED TO PRODUCE SPINAL IMPLANTS INCORPORATING THE NEW TECHNOLOGIES. ADDITIONALLY, CONTRACTING WITH REGULATORY CONSULTANTS TO GUIDE THE R&D PROCESS GOING FORWARD AND DEVELOP STRATEGIES AND PLANS FOR GAINING REGULATORY APPROVALS.
Expenses: $681K
| 2018 | 990PF | View |
| 2017 | 990PF | View |
| 2016 | 990PF | View |
| 2015 | 990PF | View |
© 2026 Granted AI